Literature DB >> 16011596

Factor VIII inhibitor associated with peginterferon.

C Herman1, L Boggio, D Green.   

Abstract

We present a case of a 53-year-old black male who developed a factor VIII inhibitor during his treatment for hepatitis C virus infection with peginterferon. The development of inhibitors against factor VIII during peginterferon therapy has been rarely reported. We have reviewed the current literature and the following case presentation provides the first demonstration, to our knowledge, in which chronic exposure to peginterferon is associated with an acquired factor VIII inhibitor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16011596     DOI: 10.1111/j.1365-2516.2005.01089.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  4 in total

1.  Is the periodic repetition of a coagulation check necessary during anti-hepatitis C virus therapy?

Authors:  F Capra; N Nicolini; M Franchini
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

Review 2.  Rituximab for eradicating inhibitors in people with acquired haemophilia A.

Authors:  Tracey Remmington; Sherie Smith
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23

Review 3.  The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.

Authors:  Giovanni D'arena; Elvira Grandone; Matteo N D Di Minno; Pellegrino Musto; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2015-09-03       Impact factor: 3.443

4.  An Acquired Factor VIII Inhibitor in a Patient with HIV and HCV: A Case Presentation and Literature Review.

Authors:  S B Zeichner; A Harris; G Turner; M Francavilla; J Lutzky
Journal:  Case Rep Hematol       Date:  2013-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.